VALSECCHI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 4.513
EU - Europa 2.295
AS - Asia 2.156
SA - Sud America 399
AF - Africa 43
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 9
Totale 9.429
Nazione #
US - Stati Uniti d'America 4.430
CN - Cina 898
SG - Singapore 641
PL - Polonia 487
UA - Ucraina 419
BR - Brasile 347
IT - Italia 341
DE - Germania 333
HK - Hong Kong 180
GB - Regno Unito 166
FI - Finlandia 163
VN - Vietnam 136
RU - Federazione Russa 103
IN - India 91
IE - Irlanda 73
FR - Francia 71
TR - Turchia 67
CA - Canada 48
CZ - Repubblica Ceca 26
BD - Bangladesh 23
BE - Belgio 23
MX - Messico 22
SE - Svezia 20
ID - Indonesia 19
JP - Giappone 18
SA - Arabia Saudita 16
AT - Austria 13
ZA - Sudafrica 13
ES - Italia 12
IQ - Iraq 12
NL - Olanda 12
AR - Argentina 11
AU - Australia 11
EC - Ecuador 9
HU - Ungheria 9
PK - Pakistan 9
CO - Colombia 8
IR - Iran 8
MA - Marocco 8
VE - Venezuela 8
KE - Kenya 7
JO - Giordania 6
UZ - Uzbekistan 6
A1 - Anonimo 5
EG - Egitto 5
PY - Paraguay 5
UY - Uruguay 5
AL - Albania 4
EU - Europa 4
KG - Kirghizistan 4
PH - Filippine 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
CH - Svizzera 3
CL - Cile 3
IL - Israele 3
LT - Lituania 3
MU - Mauritius 3
PA - Panama 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
DZ - Algeria 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
NZ - Nuova Zelanda 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GR - Grecia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
OM - Oman 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 9.429
Città #
Fairfield 487
Warsaw 483
Ashburn 412
Woodbridge 370
Jacksonville 314
Singapore 308
Ann Arbor 260
Houston 240
Chandler 230
Beijing 188
New York 184
Hong Kong 180
Seattle 179
Wilmington 178
Cambridge 167
Princeton 137
Helsinki 108
Nanjing 98
The Dalles 83
Dearborn 80
Los Angeles 78
Brescia 73
Dublin 73
Munich 63
Istanbul 58
Milan 51
Shenyang 50
Jinan 48
Des Moines 46
Nanchang 44
Moscow 42
Ho Chi Minh City 37
Boardman 36
Chicago 36
Tianjin 36
Changsha 35
São Paulo 35
Dallas 34
Hebei 34
Lancaster 34
San Francisco 29
Buffalo 28
Redondo Beach 27
Hanoi 24
Shanghai 24
Turku 24
Jiaxing 23
London 21
Dong Ket 20
Santa Clara 18
Zhengzhou 18
Brussels 17
Ningbo 17
San Diego 17
Brooklyn 16
Lanzhou 16
Rome 16
Toronto 16
Brno 15
Guangzhou 15
Tokyo 15
Montreal 14
Haikou 13
Orem 13
Denver 12
Manchester 12
Norwalk 12
Washington 12
Atlanta 11
Hangzhou 11
Phoenix 11
Taizhou 11
Chennai 10
Olomouc 10
Jakarta 9
Kunming 9
Mexico City 9
Orange 9
Rio de Janeiro 9
Verona 9
Vienna 9
Belo Horizonte 8
Boston 8
Charlotte 8
Hefei 8
Salvador 8
San Mateo 8
Stockholm 8
Taiyuan 8
Frankfurt am Main 7
Fuzhou 7
Johannesburg 7
Leawood 7
Trieste 7
Amman 6
Campinas 6
Gent 6
Nairobi 6
New Delhi 6
Poplar 6
Totale 6.395
Nome #
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 311
New Copy Number Variations in Schizophrenia 304
Farmacoterapia antipsicotica e disturbi cognitivi. 229
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 205
A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: The QUERISOLA trial. 187
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 186
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 182
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 180
Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS) 174
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 170
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 169
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 169
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 163
Comparison of quetiapine (‘Seroquel’), olanzapine and risperidone in a randomized study in patients with schizophrenia. 161
Comparison of quetiapine, olanzapine and risperidone in schizophrenia. 160
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 159
Comparison of Quetiapine, Olanzapine, and Risperidone in Patients With Schizophrenia: Interim Results of a Randomised, Rater-blinded Study. 156
Analysis of Copy Number Variations in Schizophrenia Italian Patients 154
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 151
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 151
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study 149
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 149
The role of the cytochine network in schizophrenia: an overview. 147
Interim results of a randomised, rater-blinded study comparing quetiapine, olanzapine and risperidone in patients with schizophrenia. 145
Psychopharmacological treatment of cognitive deficits in Schizophrenia and mood disorders 140
Patterns of Brain Structural Changes in First-Contact, Antipsychotic Drug-Naive Patients with Schizophrenia. 138
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 135
Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study 134
Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics 133
Quetiapine in hospitalized patients with schizophrenia refractory to treatment with first-generation antipsychotics: a 4-week, flexible-dose, single-blind, exploratory, pilot trial. 133
A multimodal imaging study of never-medicated adults with schizophrenia 132
Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients 129
Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders 129
Polymorphic CA repeat in IGF-I gene: lack of association with schizophrenia. 127
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 127
Additional Evidence for White Matter Damage in Never-Medicated Adults with Schizophrenia and Schizophreniform Disorder 126
Immediate and 8-Month Impact of a Medical Educational Course for General Practitioners on Knowledge About Schizophrenia and Its Treatment: Results of a 3-Phase Study From Brescia, Italy. 123
Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report. 123
Association study between schizophrenia and the AMPA genes GRIA1, GRIA2 AND GRIA4 122
Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review 122
Variables Associated With General Practitioners' Knowledge About and Diagnostic Skills for Schizophrenia 121
Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample 117
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 117
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients 116
Detection of high level of autozygosity in a group of Italian schizophrenia patients 115
Comparison of quetiapine, olanzapine and risperidone in a randomized study in patients with schizophrenia. 115
Manuale di clinica e riabilitazione psichiatrica. Dalle conoscenze teoriche alla pratica dei servizi di salute mentale. Vol. 2: Riabilitazione psichiatrica 115
New Copy Number Variations in Schizophrenia Italian Patients 114
The factor structure analysis for the positive and negative syndrome scale (PANSS) in pharmacogenetics and pharmacogenomics studies. 113
Relationship of IQ to neuropsychological tasks involving prefrontal cortex in schizophrenia. 113
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 112
Reduced fractional anisotropy of corpus callosum in first-contact, antipsychotic drug-naive patients with schizophrenia. 110
Cerebrovascular accidents in elderly people treated with antipsychotic drugs. A systematic review 108
Adult ADHD and sleep disorders: Prevalence, severity and predictors of sleep disorders in a sample of Italian psychiatric outpatients 108
Study of the genetic architecture behind mood disorders by whole exome sequencing on a large Italian pedigree 106
Mitochondrial DNA haplogroups and age at onset of schizophrenia 102
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 101
Esperienze di switch a cariprazina in pazienti affetti da schizofrenia con ricorrenze 100
Panic disorder with and without comorbidity: data on epidemiology, course and treatment outcome. 99
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 98
Implementing cognitive rehabilitation interventions for schizophrenia patients in mental health services: Focus on Integrated Psychological Therapy (IPT) 97
Genome-Wide pharmacogenomics analysis of early antipsychotic (risperidone) response in patients with schizophrenia 96
Paliperidone extended-release in the short- and long-term treatment of schizophrenia 95
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 92
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 91
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 83
Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study 82
La comorbidità per uso di sostanze nei disturbi psicotici e nella schizofrenia. 79
Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features 78
Paliperidone palmitate in short- and long-term treatment of schizophrenia 68
THE FACTOR STRUCTURE FOR THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) IN PHARMACOGENETICS: 102T/C 5-HT2A POLYMORPHISM AND RESPONSE TO RISPERIDONE 67
A miR-137–Related Biological Pathway of Risk for Schizophrenia Is Associated With Human Brain Emotion Processing 66
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 53
Totale 9.631
Categoria #
all - tutte 42.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.257


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021761 0 0 0 0 0 94 75 117 141 139 136 59
2021/2022577 45 105 15 32 7 23 27 33 28 58 56 148
2022/2023639 86 9 6 68 46 176 4 67 96 11 40 30
2023/2024777 41 14 70 82 46 196 31 21 119 29 18 110
2024/20251.344 19 30 15 171 154 129 96 52 133 82 272 191
2025/20261.763 263 354 212 421 322 191 0 0 0 0 0 0
Totale 9.631